» Articles » PMID: 27016546

The Single-Visit Approach As a Cervical Cancer Prevention Strategy Among Women With HIV in Ethiopia: Successes and Lessons Learned

Abstract

Introduction: Cervical cancer is the second most common form of cancer for women in Ethiopia. Using a single-visit approach to prevent cervical cancer, the Addis Tesfa (New Hope) project in Ethiopia tested women with HIV through visual inspection of the cervix with acetic acid wash (VIA) and, if tests results were positive, offered immediate cryotherapy of the precancerous lesion or referral for loop electrosurgical excision procedure (LEEP). The objective of this article is to review screening and treatment outcomes over nearly 4 years of project implementation and to identify lessons learned to improve cervical cancer prevention programs in Ethiopia and other resource-constrained settings.

Methods: We analyzed aggregate client data from August 2010 to March 2014 to obtain the number of women with HIV who were counseled, screened, and treated, as well as the number of annual follow-up visits made, from the 14 tertiary- and secondary-level health facilities implementing the single-visit approach. A health facility assessment (HFA) was also implemented from August to December 2013 to examine the effects of the single-visit approach on client flow, staff workload, and facility infrastructure 3 years after initiating the approach.

Results: Almost all (99%) of the 16,632 women with HIV counseled about the single-visit approach were screened with VIA during the study period; 1,656 (10%) of them tested VIA positive (VIA+) for precancerous lesions. Among those who tested VIA+ and were thus eligible for cryotherapy, 1,481 (97%) received cryotherapy treatment, but only 80 (63%) women eligible for LEEP actually received the treatment. The HFA results showed frequent staff turnover, some shortage of essential supplies, and rooms that were judged by providers to be too small for delivery of cervical cancer prevention services.

Conclusion: The high proportions of VIA screening and cryotherapy treatment in the Addis Tesfa project suggest high acceptance of such services by women with HIV and feasibility of implementation in secondary- and tertiary-level health facilities. However, success of cervical cancer prevention programming must address wider health system challenges to ensure sustainability and appropriate scale-up to the general population of Ethiopia and other resource-constrained settings.

Citing Articles

Interventions and Strategies to Increase Cervical Cancer Screening, Treatment, and Retention in Care among Persons with HIV in Low- and Middle-Income Countries: A Systematic Review.

Mittal R, Kabel K, Fertig M, Lee J, Mosery N, Githaiga J AIDS Behav. 2025; .

PMID: 40055221 DOI: 10.1007/s10461-025-04678-y.


Cervical cancer screening utilization among healthcare professionals in Ethiopia: systematic review and meta-analysis.

Tizazu M, Demsash A, Mamo T, Kebede T, Mihretie A, Mamo Negash K Front Glob Womens Health. 2025; 6:1467313.

PMID: 40041926 PMC: 11876396. DOI: 10.3389/fgwh.2025.1467313.


Protocol for a systematic review and meta-analysis on intention to screen for cervical cancer and predictors among women of reproductive age in Ethiopia.

Lahole B, Simon T, Ewunetu W, Kussia W BMJ Public Health. 2025; 2(1):e000585.

PMID: 40018097 PMC: 11812819. DOI: 10.1136/bmjph-2023-000585.


Study protocol for key interventions to improve the follow-up adherence postcervical precancerous lesion treatment in Ethiopia: a pragmatic randomised controlled trial.

Destaw A, Getachew S, Getachew E, Shita A, Midaksa M, Rossner S BMJ Open. 2025; 15(1):e091693.

PMID: 39773801 PMC: 11749215. DOI: 10.1136/bmjopen-2024-091693.


Prevalence of human papillomaviruses in self-collected samples among women attending antenatal care in Ethiopia: a cross-sectional study.

Runge I, Klein J, Pannen A, Abera S, Wakuma T, Gebrehiwot Y Ecancermedicalscience. 2024; 18:1739.

PMID: 39421164 PMC: 11484669. DOI: 10.3332/ecancer.2024.1739.


References
1.
Sauvaget C, Fayette J, Muwonge R, Wesley R, Sankaranarayanan R . Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet. 2011; 113(1):14-24. DOI: 10.1016/j.ijgo.2010.10.012. View

2.
Kafuruki L, Rambau P, Massinde A, Masalu N . Prevalence and predictors of Cervical Intraepithelial Neoplasia among HIV infected women at Bugando Medical Centre, Mwanza-Tanzania. Infect Agent Cancer. 2013; 8(1):45. PMC: 3833176. DOI: 10.1186/1750-9378-8-45. View

3.
Sankaranarayanan R, Rajkumar R, Esmy P, Fayette J, Shanthakumary S, Frappart L . Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer. 2007; 96(5):738-43. PMC: 2360066. DOI: 10.1038/sj.bjc.6603633. View

4.
Martin C, Tergas A, Wysong M, Reinsel M, Estep D, Varallo J . Evaluation of a single-visit approach to cervical cancer screening and treatment in Guyana: feasibility, effectiveness and lessons learned. J Obstet Gynaecol Res. 2014; 40(6):1707-16. DOI: 10.1111/jog.12366. View

5.
Blumenthal P, Lauterbach M, Sellors J, Sankaranarayanan R . Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Int J Gynaecol Obstet. 2005; 89 Suppl 2:S30-7. DOI: 10.1016/j.ijgo.2005.01.012. View